Mantle Cell Lymphoma

• FDA label_change · 2024-06-04
  FDA Approved: BRUKINSA — Supplemental Application (BeOne Medicines USA, Inc.)

  FDA approved a supplemental application for BRUKINSA (zanubrutinib) to update the product labeling.

• FDA label_change · 2022-06-30
  FDA Approved: LENALIDOMIDE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

  FDA approved a supplemental application for lenalidomide submitted by Dr. Reddy's Laboratories Inc., resulting in updated labeling for the d…

• FDA label_change · 2019-10-08
  FDA Approved: BENDEKA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for Bendeka (bendamustine hydrochloride) by Teva Pharmaceuticals to update its labeling.